ABHD11 and prostate adenocarcinoma: Thus, ABHD11 likely regulates the mitochondrial-metabolic-immune axis in PRAD by modulating 2-OG levels, linking mitochondrial dysfunction to the remodeling of an immunosuppressive microenvironment.